Vimarsana
Biggest News Aggregation in the World

Page 5 - Roberte Hoffman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roberte Hoffman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roberte Hoffman Today - Breaking & Trending Today

Kintara Therapeutics Announces Fiscal 2023 Second Quarter Financial Results and Provides Corporate Update - Vimarsana News

Kintara Therapeutics Announces Fiscal 2023 Second Quarter Financial Results and Provides Corporate Update

/PRNewswire/ -- Kintara Therapeutics, Inc. (NASDAQ: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...

Kintara Therapeutics Granted Fast Track Designation from FDA for REM-001 for Cutaneous Metastatic Breast Cancer - Vimarsana News

Kintara Therapeutics Granted Fast Track Designation from FDA for REM-001 for Cutaneous Metastatic Breast Cancer

/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...

FDA Fast Track designation for REM-001 breast cancer therapy - Vimarsana News

FDA Fast Track designation for REM-001 breast cancer therapy

REM-001, a photodynamic therapy for metastatic breast cancer was given Fast Track designation by the US Food and Drug Administration (FDA).

Kintara Therapeutics Announces Fiscal 2023 First Quarter Financial Results and Provides Corporate Update - Vimarsana News

Kintara Therapeutics Announces Fiscal 2023 First Quarter Financial Results and Provides Corporate Update

/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...

Kintara Therapeutics Announces Fiscal 2023 First Quarter Financial Results and Provides Corporate Update - Vimarsana News

Kintara Therapeutics Announces Fiscal 2023 First Quarter Financial Results and Provides Corporate Update

/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...